News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
FDA approval: Zenocutuzumab for NRG1+ NSCLC – IASLC
The International Association for the Study of Lung Cancer/X
Jan 23, 2025, 16:29

FDA approval: Zenocutuzumab for NRG1+ NSCLC – IASLC

The International Association for the Study of Lung Cancer (IASLC) shared a post on X:

“ICYMI, the FDA recently approved zenocutuzumab for NSCLC with an NRG1 fusion.

Catch this all-new episode of Lung Cancer Considered as Stephen V Liu and Alison Schram discuss this breakthrough and what this approval means for treating NSCLC patients with an NRG1 fusion

Listen now.”

More posts featuring IASLC.

Alison Schram cancer FDA ICYMI Lung cancer NRG1 fusion NSCLC OncoDaily Oncology Stephen V Liu zenocutuzumab
Special Coverage
Blog
Apr 2, 2025, 14:29
Sotirios Bisdas: The integration of AI in medical imaging and oncology is transforming healthcare
Blog
Apr 2, 2025, 14:24
Webinar on the ARIA Guide for childhood cancer treatment - The Dorcas Cancer Foundation
Societies
Apr 2, 2025, 14:12
Fellows of ASCO (FASCO) Recipients For Last Quarter
Blog
Apr 2, 2025, 14:05
Isabel Mestres: Incredible work in cancer care in India
Blog
Apr 2, 2025, 13:48
David Planchard: Lung preceptorship leading by Fabrice Barlesi at Gustave Roussy
Blog
Apr 2, 2025, 13:40
Runcie C.W. Chidebe: Creating prostate cancer awareness and urging the government to fund research
Blog
Apr 2, 2025, 13:28
Gratitude for NIH Leaders: Honoring their Dedication and Impact
Blog
Apr 2, 2025, 13:20
Michael Sapienza: National Colorectal Cancer Awareness Month was full of activities
Drugs
Apr 2, 2025, 13:07
Patrick Hwu: Can neoantigen-specific TILs improve immunotherapy for gastrointestinal cancers?
Blog
Apr 2, 2025, 13:00
Annals of Research in Oncology - The new issue is now available
Blog
Apr 2, 2025, 12:56
Ajay Aggarwal: How NATCAN differs from other international audit programs and its future areas for development
Blog
Apr 2, 2025, 12:47
Akhil Santhosh: Incorporation of triapine (T) to cisplatin chemoradiation (CRT) for locally advanced cervical and vaginal cancer